Cyclosporine trough levels and its side effects in kidney transplant recipients

Iranian Journal of Kidney Diseases

Volumn 4, Issue 2, 2010, Pages 153-157

  Hami, Maryam ^a   Mojahedi, Mohammad Javad ^a   Naghibi, Masih ^a   Shakeri, Mohammad Taghi ^a   Sharifipour, Farzaneh ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adverse effects; Cyclosporine; Kidney transplantation

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; EVENING DOSAGE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HAND TREMOR; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; SYSTOLIC BLOOD PRESSURE;

ADULT; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; HEADACHE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREMOR; YOUNG ADULT;

EID: 77953175445     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hardinger KL, Schnitzler MA, Koch MJ, et al. Cyclosporine minimization and cost reduction in renal transplant recipients receiving a C2-monitored, cyclosporine-based quadruple immunosuppressive regimen. Transplantation. 2004;78:1198-203.
2. Morris RG. Cyclosporin therapeutic drug monitoring - an established service revisited. Clin Biochem Rev. 2003;24:33-46.
3. Wacke R, Drewelow B, Kundt G, Hehl EM, Bast R, Seiter H. Cyclosporine A: peak or trough level monitoring in renal transplant recipients? Transplant Proc. 2001;33:3122-3.
4. Keown PA. New concepts in cyclosporine monitoring. Curr Opin Nephrol Hypertens. 2002;11:619-26.
5. Citterio F, Scata MC, Romagnoli J, Nanni G, Castagneto M. Results of a three-year prospective study of C2 monitoring in long-term renal transplant recipients receiving cyclosporine microemulsion. Transplantation. 2005;79:802-6.
6. Gadela SR, Varma PP, Baliga KV. 3 year prospective evaluation of conversion to C2 monitoring of Renal Transplantation Recipient. Indian J Nephrol. 2004;14:141.
7. Perico N, Ruggenenti P, Gotti E, et al. In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial. Kidney Int. 2004;65:1084-90.
8. Holt GR, Holt JE. Lacerations of the lacrimal apparatus, parotid duct, and facial nerve: case report. J Trauma. 1976;16:414-9.
9. Yoshimura N, Okamoto M, Akioka K, Kaihara S. Optimization of the use of cyclosporine in renal transplantation. Transplant Proc. 2004;36:181S-5S.
10. Paul LC, de Fijter JH. Cyclosporine-induced renal dysfunction. Transplant Proc. 2004;36:224S-8S.
11. Danovitch GM. Immunosuppressive medications and protocols for kidney transplantation. In: Danovitch GM, editor. Handbook of kidney transplantation. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 84-90.
12. Ponticelli C. Generic cyclosporine: a word of caution. J Nephrol. 2004;17 Suppl 8:S20-4.
13. Braun F, Armstrong VW, Lorf T, et al. Comparison of trough level and C(2) cyclosporine blood concentration monitoring in outpatient kidney transplant recipients. Transplant Proc. 2001;33:3108-9.
14. Saint-Marcoux F, Rousseau A, Le Meur Y, et al. Influence of sampling-time error on cyclosporine measurements nominally at 2 hours after administration. Clin Chem. 2003;49:813-5.
15. [No author listed]. Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation. Am J Transplant. 2002;2:148-56.
16. Brunet M, Millan O, Jimenez O, et al. New concepts in cyclosporine pharmacokinetic and dynamic monitoring: the impact of concomitant immunosuppression on target C2 concentrations. Transplant Proc. 2004;36:437S-41S.
17. Rodrigo E, Ruiz JC, Angeles de Cos M, et al. Correlation of C0 and C2 levels with cyclosporine side effects in kidney transplantation. Transplant Proc. 2009;41:2328-31.
18. Halim MA, Said T, Al-Otaibi T, et al. Single daily dose administration of cyclosporine in renal transplant recipients. Transplant Proc. 2007;39:1225-7.